Shirley, NY, 2025-03-26 — /EPR Network/ — With the increasing use of personalized medicine and complex therapeutic targets, the requirement for high-quality antibodies has never [read full press release…]
Shirley, NY, 2024-Aug-03 — /EPR Network/ — The growing interest in TNFRSF9 (also known as CD137, 4-1BB) stems from its role as a co-stimulatory receptor [read full press release…]
Shirley, NY, 2024-Jun-15 — /EPR Network/ — Leveraging years of expertise and cutting-edge technology, Creative Biolabs commits to delivering state-of-the-art solutions for ADC development, positioning [read full press release…]
Shirley, NY, 2023-Sep-23 — /EPR Network/ — Affecting millions of individuals worldwide, autoimmune diseases pose significant challenges to both patients and researchers seeking to understand [read full press release…]
